v3.26.3
Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Revenues        
Gross premiums written (Note 5) $ 2,104,008 $ 2,323,626 $ 8,577,305 $ 9,900,309
Net premiums written (Note 5) 1,665,477 2,057,802 6,620,733 8,271,601
Decrease (increase) in unearned premiums 435,599 376,003 (136,522) (704,861)
Net premiums earned (Note 5) 2,101,076 2,433,805 6,484,211 7,566,740
Net investment income (Note 3) 440,853 438,354 1,293,844 1,256,815
Net foreign exchange gains (losses) 831 877 (15,533) 2,209
Equity in earnings (losses) of other ventures 28,539 12,551 66,853 50,712
Other income (loss) 14 705 5,740 4,243
Net realized and unrealized gains (losses) on investments (Note 3) (879,843) 311,890 (1,180,128) 994,550
Total revenues 1,691,470 3,198,182 6,654,987 9,875,269
Expenses        
Net claims and claim expenses incurred (Notes 5 and 6) 1,026,492 878,820 2,952,841 4,664,701
Acquisition expenses 542,893 659,723 1,628,022 1,949,763
Operational expenses 105,600 125,073 289,382 350,996
Corporate expenses 16,685 23,414 54,826 70,005
Interest expense (Note 7) 31,794 30,582 95,358 89,461
Total expenses 1,723,464 1,717,612 5,020,429 7,124,926
Income (loss) before taxes (31,994) 1,480,570 1,634,558 2,750,343
Income tax benefit (expense) 30,153 (148,860) (142,231) (280,204)
Net income (loss) (1,841) 1,331,710 1,492,327 2,470,139
Net (income) loss attributable to redeemable noncontrolling interests (Note 8) (150,700) (415,200) (688,411) (548,287)
Net income (loss) attributable to RenaissanceRe (152,541) 916,510 803,916 1,921,852
Dividends on preference shares (Note 10) (8,843) (8,843) (26,531) (26,531)
Net income (loss) available (attributable) to RenaissanceRe common shareholders $ (161,384) $ 907,667 $ 777,385 $ 1,895,321
Net income (loss) available (attributable) to RenaissanceRe common shareholders per common share – basic (in dollars per share) $ (4.02) $ 19.47 $ 18.47 $ 39.60
Net income (loss) available (attributable) to RenaissanceRe common shareholders per common share – diluted (in dollars per share) $ (4.02) $ 19.40 $ 18.39 $ 39.46